ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Zenas BioPharma Inc

Zenas BioPharma Inc (ZBIO)

7,85
0,07
(0,90%)
Fermé 20 Janvier 10:00PM
7,85
-0,03
(-0,38%)
Après les heures de négociation: 10:02PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
7,85
Prix Achat
7,00
Prix Vente
35,00
Volume échangé
112 524
7,68 Fourchette du Jour 7,992
7,495 Plage de 52 semaines 26,11
Cap du marché
Clôture Veille
7,78
Ouverture
7,80
Dernière Transaction
45
@
7.5
Dernière heure de transaction
Volume financier
US$ 879 247
VWAP
7,8139
Volume moyen (3 m)
318 797
Actions en circulation
41 791 037
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-8,87
Bénéfice par action (BPA)
-0,89
Chiffre d'affairess
50M
Bénéfice net
-37,12M

À propos de Zenas BioPharma Inc

Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout t... Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout the biopharmaceutical industry to identify, acquire and develop product candidates that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Our lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We are developing obexelimab for patients in several autoimmune diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Zenas BioPharma Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ZBIO. Le dernier cours de clôture d'Zenas BioPharma était de US$7,78. Au cours de la dernière année, les actions de Zenas BioPharma ont été négociées dans une fourchette de prix de US$ 7,495 à US$ 26,11.

Zenas BioPharma compte actuellement 41 791 037 actions en circulation. La capitalisation boursière d'Zenas BioPharma est de US$325,13 million. Zenas BioPharma a un ratio cours/bénéfice (ratio PE) de -8.87.

ZBIO Dernières nouvelles

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

-Completed initial public offering, raising $258.7 million in gross proceeds, to fund the expanded clinical development of lead product candidate, obexelimab, and support company growth strategy...

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

-INDIGO is the largest clinical trial conducted in patients living with IgG4-RD- -Topline INDIGO results expected by the end of 2025- WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Zenas...

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the...

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the...

ProShares Announces ETF Share Splits

ProShares, a premier provider of ETFs, announced today forward and reverse share splits on 20 of its ETFs. The splits will not change the total value of a shareholder's investment...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.3-14.20765027329.159.157.4951507048.04443536CS
4-1.78-18.48390446529.6310.957.4954025049.5757277CS
12-15.54-66.438648995323.3923.967.49531879711.22354561CS
26-2.1704-21.659813979510.020426.117.49518636013.14382616CS
52-2.1704-21.659813979510.020426.117.4959392013.14382616CS
156-2.1704-21.659813979510.020426.117.4953143113.14382616CS
260-0.87-9.977064220188.7226.117.4952247912.97404995CS

ZBIO - Frequently Asked Questions (FAQ)

What is the current Zenas BioPharma share price?
The current share price of Zenas BioPharma is US$ 7,85
How many Zenas BioPharma shares are in issue?
Zenas BioPharma has 41 791 037 shares in issue
What is the market cap of Zenas BioPharma?
The market capitalisation of Zenas BioPharma is USD 325,13M
What is the 1 year trading range for Zenas BioPharma share price?
Zenas BioPharma has traded in the range of US$ 7,495 to US$ 26,11 during the past year
What is the PE ratio of Zenas BioPharma?
The price to earnings ratio of Zenas BioPharma is -8,87
What is the cash to sales ratio of Zenas BioPharma?
The cash to sales ratio of Zenas BioPharma is 6,59
What is the reporting currency for Zenas BioPharma?
Zenas BioPharma reports financial results in USD
What is the latest annual turnover for Zenas BioPharma?
The latest annual turnover of Zenas BioPharma is USD 50M
What is the latest annual profit for Zenas BioPharma?
The latest annual profit of Zenas BioPharma is USD -37,12M
What is the registered address of Zenas BioPharma?
The registered address for Zenas BioPharma is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Zenas BioPharma operate in?
Zenas BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M
Aucune Discussion Trouvée
Ajouter une Discussion